Unexpected brain mechanism challenges assumptions about GLP-1s
For decades, obesity medications produced only modest weight loss. But in recent years, Ozempic and related GLP-1 therapies have transformed the field, enabling sustained weight loss of 10% to 15% or more. Despite their success, however, scientists have not fully understood how these drugs work in the brain.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
